Early Conversion to Belatacept-based Therapy Improves Graft Function in Renal Transplant Patients

被引：0
|
作者：
Huang, N. [1 ]
Yang, C. J. [2 ]
Movileanu, I. [1 ]
Dvorai, R. H. [3 ]
Ecal, K. M. [1 ]
Saidi, R. F. [1 ]
Senay, A. N. Ayla [1 ]
Gallay, B. [4 ]
Hanlon, M. J. [1 ]
Narsipur, S. [4 ]
Laftavi, M. R. [1 ]
Shahbazov, R. [1 ]
机构：
[1] SUNY Upstate Med Univ, Surg, Syracuse, NY 13210 USA
[2] SUNY Upstate Med Univ, Pharm, Syracuse, NY 13210 USA
[3] SUNY Upstate Med Univ, Pathol, Syracuse, NY 13210 USA
[4] SUNY Upstate Med Univ, Med, Syracuse, NY 13210 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
935
引用
收藏
页码：692 / 692
页数：1
相关论文
共 50 条
  • [1] Conversion to Belatacept-Based Immunosuppression Therapy in Renal Transplant Patients
    Paz, M.
    Roberti, J.
    Mos, F.
    Cicora, F.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 2987 - 2990
  • [2] Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients
    Moein, Mahmoudreza
    Dvorai, Reut Hod
    Li, Benson W.
    Fioramonti, P. J.
    Schilsky, Juliana B.
    Thankachan, Reeba
    Yang, Christine
    Saidi, Reza F.
    Shahbazov, Rauf
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [3] Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients
    Wojciechowski, David
    Chandran, Sindhu
    Vincenti, Flavio
    CLINICAL TRANSPLANTATION, 2017, 31 (05)
  • [4] Safety of Early Transition to Belatacept-Based Immunosuppression in Kidney Transplant Patients
    Schilsky, J.
    Dvorai, R. H.
    Gallay, B.
    Iskhagi, S.
    Yang, C.
    Hanlon, M.
    Saidi, R.
    Shahbazov, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S847 - S847
  • [5] Belatacept-based therapy cost effective in kidney transplant
    Reactions Weekly, 2013, 1455 (1) : 3 - 3
  • [6] Early conversion to belatacept in patients with poor or delayed graft function
    Liriano-Ward, Luz
    Nair, Vinay
    Shapiro, Ron
    Florman, Sander S.
    TRANSPLANTATION, 2016, 100 (07) : S84 - S84
  • [7] Renal Outcomes of High-Risk Kidney Transplant Recipients After Conversion to Belatacept-Based Immunosuppression
    Anders, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S847 - S848
  • [8] Optimizing of Belatacept-Based Salvage Immunosuppression in Kidney Transplant Patients
    Schilsky, Juliana
    Dvorai, Reut Hod
    Saracino, Giovanna
    Suo, Liye
    Iskhagi, Samir
    Saidi, Reza F.
    Shahbazov, Rauf O.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S497 - S497
  • [9] Late conversion from tacrolimus to a belatacept-based immunosuppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism
    Schulte, Kevin
    Vollmer, Clara
    Klasen, Vera
    Braesen, Jan Hinrich
    Puechel, Jodok
    Borzikowsky, Christoph
    Kunzendorf, Ulrich
    Feldkamp, Thorsten
    JOURNAL OF NEPHROLOGY, 2017, 30 (04) : 607 - 615
  • [10] Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
    Kirk, Allan D.
    Adams, Andrew B.
    Durrbach, Antoine
    Ford, Mandy L.
    Hildeman, David A.
    Larsen, Christian P.
    Vincenti, Flavio
    Wojciechowski, David
    Woodle, E. Steve
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (05) : 1691 - 1698
12345